Global Ventricular Assist Device Market Set for Strong Expansion Reaching $4.34 Billion by 2030 at 12.8% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Ventricular Assist Device Market At The End Of The 2026–2030 Forecast Period?
The ventricular assist device market size has seen rapid growth in recent years. This market is expected to expand from $2.37 billion in 2025 to $2.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. Historically, this growth can be attributed to several factors including the rising prevalence of end-stage heart failure, the scarcity of donor hearts, progress in mechanical circulatory support technologies, increasing clinical acceptance of LVAD therapy, and enhanced surgical outcomes.
The ventricular assist device market size is projected for swift expansion in the upcoming years. It is anticipated to reach $4.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. This expansion during the forecast period is fueled by an increasing elderly demographic suffering from cardiac conditions, a rise in the use of long-term mechanical assistance, innovations in device robustness, broader implementation of in-home patient oversight, and increased funding for advanced cardiac treatment facilities. Key developments expected in this period encompass progress in miniature implantable pump designs, wider acceptance of continuous-flow technologies, incorporation of remote patient surveillance functionalities, enhanced use of biocompatible materials, and an increase in destination therapy applications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp
What Primary Drivers Are Shaping The Development Of The Ventricular Assist Device Market?
The growing occurrence of cardiovascular disorders is propelling the expansion of the Ventricular Assist Device Market. These heart conditions stem from factors such as elevated blood pressure, smoking, high cholesterol, and sedentary lifestyles. Additionally, the rising prevalence of cardiovascular disorders is linked to non-communicable diseases like diabetes, chronic respiratory illnesses, and heart attacks caused by hypertension. This notable rise in heart-related ailments is anticipated to amplify the need for ventricular assist devices, which serve as crucial life support for critically ill heart patients. For example, data from the Centers for Disease Control and Prevention, a US-based public health institute, indicated in October 2024 that in 2023, approximately 1 out of every 6 deaths attributed to cardiovascular diseases occurred in adults under 65 years old, with a total of 919,032 individuals succumbing to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the increasing prevalence of cardiovascular disorders is projected to fuel demand within the Ventricular Assist Device Market. Increased understanding of heart failure treatment is anticipated to stimulate expansion in the Ventricular Assist Device Market. Heart failure is a condition where the heart becomes weak or rigid, leading to less efficient blood pumping. It signifies the heart’s inability to supply sufficient blood to the body, often resulting from coronary artery disease, heart attacks, high blood pressure, or damage to the heart muscle. Enhanced public awareness concerning heart failure therapies is projected to increase the deployment of ventricular assist devices for managing this condition. For instance, in September 2025, the British Heart Foundation, a UK-based nonprofit organization, projected that by 2030, the number of individuals living with cardiovascular disease in the UK might climb by approximately 1 million, and by 2040, this figure could grow by about 2 million beyond current levels. Therefore, the heightened awareness of heart failure treatment is expected to drive the growth of the Ventricular Assist Device Market.
What Segment Types Make Up The Ventricular Assist Device Market?
The ventricular assist device market covered in this report is segmented –
1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)
2) By Flow Mechanism: Pulsatile Flow, Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres
Subsegments:
1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs
2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs
3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs
Which Market Trends Are Creating New Opportunities In The Ventricular Assist Device Market?
Leading companies in the ventricular assist device (VAD) market are concentrating on technological advancements, such as laser-welding technology, to decrease the size and weight of implantable devices, improve biocompatibility, and enhance structural integrity. Utilizing precise laser welding enables manufacturers to produce lighter, more compact pumps without compromising durability, ultimately making the devices more appropriate for a broader spectrum of patients and improving long-term outcomes. For example, in March 2024, Evaheart Medical, a China-based artificial heart company, introduced its EVA-Pulsar ventricular assist device, which weighs only 262 grams, a benefit of laser-welding technology. This lightweight construction helps to closely simulate natural pulse pressure (20–30 mmHg) and supports more physiological cardiac output, thereby reducing risks associated with continuous-flow devices. The EVA-Pulsar has also received regulatory approval in Japan, and clinical trials are currently ongoing in the U.S., indicating its potential worldwide.
Who Are The Key Players Driving Competition In The Ventricular Assist Device Market?
Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd
Read the full ventricular assist device market report here:
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
How Does The Ventricular Assist Device Market Perform Across Major Global Regions?
North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Ventricular Assist Device Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6680&type=smp
Browse Through More Reports Similar to the Global Ventricular Assist Device Market 2026, By The Business Research Company
Left Ventricular Assist Devices Market Report 2026
Cardiac Assist Devices And Equipment Market Report 2026
Heart Pump Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
